HARMAN FINOCHEM LTD

Overview

HARMAN FINOCHEM LTD is an active pharmaceutical ingredient (API) supplier with 36 active FDA Type II Drug Master Files, covering ALLOPURINOL; BENZTROPINE MESYLATE USP; CARISOPRODOL USP; CHOLINE FENOFIBRATE; CLOFAZIMINE; CUPRIC SULFATE USP.

API / Drug Master Files

HARMAN FINOCHEM LTD holds 36 active (37 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• CLOFAZIMINEActive2024-06-01
• LINAGLIPTINActive2023-09-27
• SELENIOUS ACIDActive2022-10-01
• CUPRIC SULFATE USPActive2022-09-30
• MANGANESE SULFATE USPActive2022-09-30
• R-OXYBUTYNIN HYDROCHLORIDEActive2022-09-26
• POTASSIUM ACETATE USPActive2022-05-06
• FOSPROPOFOL DISODIUMActive2020-11-28
• DESETHYLOXYBUTYNIN HYDROCHLORIDEActive2020-09-10
• VALSARTAN USPActive2019-11-19
• GLYCOPYRROLATE TOSYLATEActive2019-09-24
• SACUBITRIL/VALSARTANActive2019-02-01
• BENZTROPINE MESYLATE USPActive2018-09-30
• NOREPINEPHRINE BITARTRATE USPActive2018-09-30
• EFINACONAZOLEActive2017-12-06

Showing 15 of 37 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to HARMAN FINOCHEM LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.